Evidence map›Paper›PMID 37812352›Full record

ArticleMolecular biology reports2023

NGS study in a sicilian case series with a genetic diagnosis for Gerstmann-Sträussler-Scheinker syndrome (PRNP, p.P102L).

Michele Salemi, Luana G M Mandarà, Maria Grazia Salluzzo, Francesca A Schillaci, Roberto Castiglione, Angela Cordella, Roberta Iorio, Concetta Simona Perrotta, Raffaele Ferri, Corrado Romano

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. An Overview of Genetics of Moyamoya: BeyondInternational journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Michele SalemiOasi Research Institute-IRCCS, Troina, EN, Italy. msalemi@oasi.en.it.ORCID http://orcid.org/0000-0003-1075-8993
Luana G M MandaràU.O.S. Medical Genetics, Maria Paternò Arezzo Hospital, Ragusa, RG, Italy.
Maria Grazia SalluzzoOasi Research Institute-IRCCS, Troina, EN, Italy.
Francesca A SchillaciOasi Research Institute-IRCCS, Troina, EN, Italy.
Roberto CastiglioneDepartment of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Angela CordellaGenomix4Life Srl, Baronissi, SA, Italy.
Roberta IorioGenomix4Life Srl, Baronissi, SA, Italy.
Concetta Simona PerrottaU.O.S. Medical Genetics, Maria Paternò Arezzo Hospital, Ragusa, RG, Italy.
Raffaele FerriOasi Research Institute-IRCCS, Troina, EN, Italy.
Corrado RomanoOasi Research Institute-IRCCS, Troina, EN, Italy.
Oasi Maria SS · ITAzienda Usl 8 Arezzo · ITCenter for Genomic Science · ITUniversity of Catania · IT

Funding

Ministero della Salute (RC 2773804)
6 · The paper itself

Abstract

backgroundGerstmann Sträussler Scheinker (GSS) is an inherited, invariably fatal prion disease. Like other human prion diseases, GSS is caused by missense mutations in the prion protein (PrP) gene (PRNP), and by the formation and overtime accumulation of the misfolded, pathogenic scrapie PrP (PrPSc). The first mutation identified in the PRNP gene, and the one blamed as the main cause of the disease, is c.C305T:p.P102L. METHODS AND

resultsThe Sanger sequencing method was performed on the PRNP gene for the detection of c.C305T:p.P102L mutations in a cohort of 10 subjects; moreover, a study was carried out, using Next Generation Sequencing (NGS), by sequencing a group of genes related to amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), movement disorders and dementia which show a phenotypic profile similar to that of GSS. The results obtained from the study using NGS indicate the potential role of other genetic variants which could contribute to the various GSS phenotypes.

conclusionsIn conclusion, we highlight the large clinical variability in subjects presenting with GSS and p.P102L, as well as the hypothesis that the mutation in PrP codon 102 alone is not sufficient to trigger the cardinal clinical signs of the disease; furthermore, we do not exclude the possibility that further genetic variants play a decisive role in the aspects of the various phenotypes with which GSS manifests itself.

Indexed as

Gerstmann-Straussler-Scheinker DiseasePrionsAnimalsHigh-Throughput Nucleotide SequencingHumansMutationPrion ProteinsPrion ProteinsPrionsPRNP protein, humanGerstmann-Sträussler-Scheinker syndromeNeurodegenerative diseasesNext generation sequencingPRNP gene

Identifiers

PMID37812352
OpenAlexW4387439455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.